Related Experiment Video
Updated: May 21, 2026

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
Evaluation of a revised U.S. Food and Drug Administration method for the detection of Cronobacter in powdered infant
Yi Chen1, Kathy E Noe, Sandra Thompson
1Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, Maryland 20740, USA. yi.chen@fda.hhs.gov
Insights
A new U.S. Food and Drug Administration (FDA) method for Cronobacter detection in infant formula is faster and more accurate than the previous standard. This revised method significantly improves Cronobacter analysis in powdered infant formula.
Area of Science:
- Food safety microbiology
- Analytical chemistry
- Microbial detection methods
Background:
- Cronobacter species are a concern in powdered infant formula.
- Accurate and rapid detection methods are crucial for public health.
- The U.S. Food and Drug Administration (FDA) sought to improve existing detection protocols.
Purpose of the Study:
- To validate a revised FDA method for Cronobacter isolation and detection in powdered infant formula.
- To compare the performance of the revised method against the reference FDA method.
- To assess the integration of updated PCR protocols and VITEK 2 systems.
Main Methods:
- The revised method combines real-time PCR, chromogenic agars, and RAPID ID 32E biochemical tests.
- A collaborative study involved four laboratories analyzing casein- and soy-based formulas.
- Formulas were inoculated with various Cronobacter strains for testing.
Main Results:
- The revised FDA method demonstrated significantly better performance compared to the reference FDA method.
- Valid results were obtained from 216 test portions and controls.
- The revised method offers expedited analysis within 24 to 48 hours.
Conclusions:
- The revised FDA method is a more effective and efficient approach for Cronobacter detection in powdered infant formula.
- This advancement enhances food safety and reduces analysis time.
- Further integration of PCR and VITEK 2 is recommended for a complete detection procedure.
Abstract:
A revised U.S. Food and Drug Administration (FDA) method for the isolation and detection of Cronobacter from powdered infant formula was recently developed, which combines real-time PCR, chromogenic agars, and RAPID ID 32E biochemical tests. This method provides an expedient analysis within 24 to 48 h. A collaborative validation study involving four different laboratories was conducted to compare the revised FDA method with the reference FDA method using casein- and soy-based powdered infant formula inoculated with different Cronobacter strains. Valid results from 216 test portions and controls from collaborating laboratories were obtained and showed that the revised FDA method performed significantly better than the reference FDA method. Newly revised PCR protocols and VITEK 2 were also evaluated to be integrated into the complete detection procedure.
Related Concept Videos
Investigation of Disease Outbreaks
Clinically Relevant Drug Product Specifications: Methods of Establishment
Drug Regulation

